Stay updated on GeneNews LimitedPress Releases

Sign up to get notified when there's something new on the GeneNews LimitedPress Releases page.
Latest website image capture
Clouds background image

Latest updates to the GeneNews LimitedPress Releases page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Page now features new high-importance Genentech press releases and 2025 dates, including Phase III data and new launches; older, lower-importance updates have been removed to emphasize current news.
    Difference
    70%
    Check dated 2025-10-19T16:34:43.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Replace a lymphoma treatment news item with a first-line maintenance therapy approval for SCLC; the page content now centers on Tecentriq plus lurbinectedin rather than Lunsumio/Polivy.
    Difference
    8%
    Check dated 2025-10-05T10:27:58.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added two new Genentech study news items (ECTRIMS 2025 data for Ocrevus/Fenebrutinib; positive Giredestrant Phase III result) and a future date; removed older updates on Verona Study and prasinezumab Phase III advancement. The page is being refreshed with newer trial results and conference data, de-emphasizing the older Verona and prasinezumab items.
    Difference
    65%
    Check dated 2025-09-28T03:24:01.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page has been updated to include new data on Genentech's Vabysmo and Zilebesiran, while previous entries regarding Tecentriq and Itovebi have been removed.
    Difference
    63%
    Check dated 2025-09-06T15:25:24.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now includes a significant announcement about Genentech and Roche breaking ground on a new manufacturing facility in Holly Springs, North Carolina, while a previous update regarding Fenebrutinib's effectiveness in treating relapsing multiple sclerosis has been removed.
    Difference
    15%
    Check dated 2025-08-30T12:10:39.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The web page has removed several key sections related to patient support services, including information about the Genentech Patient Foundation, insurance coverage, clinical trials, and disease education.
    Difference
    6%
    Check dated 2025-08-09T00:06:37.000Z thumbnail image

Stay in the know with updates to GeneNews LimitedPress Releases

Enter your email address, and we'll notify you when there's something new on the GeneNews LimitedPress Releases page.